Metastasis and Cachexia

Molecular Medicine, 2023

Full text Open access: Gold Metadata (CSL-JSON)
DOI 10.1007/978-3-031-27133-5_32
Data confidence 85 high
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

In this chapter, we will understand that malignant primary tumors become dangerous when angiogenesis allows their massive growth and in particular when some of the cancer cells spread to other organs and form metastases. Cancer cells that have obtained the hallmark “activating invasion and metastasis” use the EMT process, in order to leave the malignant primary tumor. They circulate in the blood stream until they colonize in distant organs, which often follows a specific tropism. The metastatic cascade filters for very potent few cancer cells that grow from micrometastases to macrometastases, but the clinical manifestation of metastases often takes years. Metastatic tumors take not only space and resources of their host tissues but they impact also other organs, such as skeletal muscle, via secreted cytokines and other factors. This leads in the majority of metastatic cancer patients to the muscle wasting syndrome cachexia, which finally causes multiorgan failure and death.